Drug-name mix-ups hurt patients, getting worse

By Maggie Fox, Health and Science Editor

WASHINGTON (Reuters) - Dr. Julius Pham's stomach churned when he saw a critically ill heart patient getting an antibiotic instead of a drug to support his blood pressure -- the kind of mix-up that is increasingly common in the United States, according to a new report.

"If you have ever had that sinking feeling that drops to the bottom of your stomach, I had it," Pham, then a critical care physician at Johns Hopkins University in Baltimore, told reporters. "Unfortunately, the patient did not do well."

A nurse had confused Levophed, which can boost blood pressure, with the antibiotic Levaquin.

The rate of drug name mix-ups has more than doubled since 2004, the U.S. Pharmacopeia said in a report on Tuesday.

The group, which regulates the generic names of drugs and advises pharmaceutical companies, reviewed more than 26,000 records and identified 1,470 unique drugs involved in errors due to similar brand or generic names.

"Together, these drug names contributed to more than 3,170 pairs -- nearly double the 1,750 product pairs appearing on USP's 2004 list," the organization said in a statement.

"According to this report's findings, 1.4 percent of the errors resulted in patient harm, including seven that may have caused or contributed to patient deaths."

The top 10 drugs sold in the United States in 2006 all made the mix-up list, including cholesterol drug Lipitor, heart drugs Toprol and Norvasc, antidepressant Lexapro, stomach acid pill Nexium and asthma drug Singulair.